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Background: Cardiac sarcoidosis (CS) is associated with poor outcomes, but detection remains difficult. Few studies evaluate 
18-fluorodeoxyglucose (18-FDG) positron emission tomography (PET) and cardiac magnetic resonance imaging (MRI) for CS diagnosis. None 
examine a novel hybrid PET-MR approach. We sought to examine the diagnostic accuracy of hybrid PET-MR imaging for CS detection.
Methods: 51 consecutive patients with biopsy-proven or clinically suspected CS (age 48 ± 13 years, 32% males) underwent hybrid PET-MR 
imaging. 18-FDG tracer uptake and late gadolinium enhancement (LGE) were qualitatively assessed on a binary scale and quantitatively by 
measuring standardised uptake value (SUV) and % LGE detected in each myocardial segment. Sensitivity and specificity of PET-MR for CS diagnosis 
was calculated. Inter-modality agreement was performed by the Cohen κ method. Coefficient of variance was performed to determine whether SUV 
quantification analysis discriminated between CS presence and absence.
results: 37 patients (73%) had confirmed sarcoidosis; 46% were histologically proven and 59% had cardiac involvement according to JMHW 
guidelines. FDG uptake on PET-MR was equivalent to PET-CT (p<0.001), confirming that simultaneous hybrid PET-MR is feasible. When considered in 
isolation, sensitivity of PET and MR at detecting abnormalities was 0.65 and 0.6, respectively. In contrast, hybrid imaging had sensitivity, specificity, 
positive and negative predictive values of 0.89, 0.42, 0.8 and 0.6, respectively in detecting probable cardiac sarcoidosis; sensitivity for detecting 
confirmed CS was 100%. Notably, there was poor inter-modality agreement between the location of increased SUV and LGE (k = 0.021). This may 
reflect the natural history of CS with progression from inflammation to scar and also account for the sensitivity of hybrid imaging. Coefficient of 
variance analysis of SUV uptake suggested that a COV above 25% predicted CS.
conclusions: This is the first study to describe the feasibility and diagnostic accuracy of novel hybrid cardiac PET-MR imaging in CS. This technique 
may allow for more accurate and earlier diagnoses and titration of therapy according to disease activity.
